Rituxan approved for chronic lymphocytic leukemia - MPR
Links shared publicly online about this topic.
- 1,370total visits
Rituxan approved for chronic lymphocytic leukemia - MPR
empr.com —
View full resource at empr.com
Tags: Leukemia, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Medication, Rheumatoid Arthritis Medication, FDA, Rituxan, MabThera, Genentech
Most Recently Shared on February 19, 2010 at 3:50 pm By:
MPR News: Rituxan approved for chronic lymphocytic leukemia: The FDA has approved Rituxan (rituximab, from Genente... http://bit.ly/deIPpG
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
drugs.com — “Rituxan (rituximab) is used to treat Chronic Lymphocytic Leukemia. Includes Rituxan side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 22, 2010 at 11:41 pm By:
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia - http://bit.ly/960vQR
UPDATE 1-US approves Roche's Rituxan cancer drug for CLL | Reuters
reuters.com — “* FDA approves Rituxan for most common adult leukemia * Approved as first-line CLL treatment * Can also be used after other drugs fail * Had 2009 sales of $5.6 bln NEW YORK, Feb 18 (Reuters) -” View full resource at reuters.com
Most Recently Shared on February 20, 2010 at 3:00 pm By:
FDA approves use of Rituxan for chronic lymphocytic leukemia. http://www.reuters.com/article/idUSN1820063720100218
Genentech And Biogen Idec Receive A Complete Response From The FDA For Rituxan For Chronic Lymphocytic Leukemia
medicalnewstoday.com — “Genentech, inc., a wholly-owned member of the roche group (six: ro, rog; otcqx: rhhby), and biogen idec (nasdaq: biib) announced today that the u.s. food and drug administration (fda) issued a com” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 9:20 am By:
Genentech And Biogen Idec Receive A Complete Response From The FDA For Rituxan For Chronic Lymphocytic Leukemia.. http://tinyurl.com/yhx227f
FDA Approves Arzerra (ofatumumab) for Chronic Lymphocytic Leukemia
drugs.com — “Arzerra (ofatumumab) is used to treat chronic lymphocytic leukemia. Includes Arzerra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 27, 2009 at 9:55 pm By:
FDA Approves Arzerra (ofatumumab) for Chronic Lymphocytic Leukemia - http://bit.ly/yxvVM
FDA Approves New Treatment For Chronic Lymphocytic Leukemia
medicalnewstoday.com — “The u.s. food and drug administration approved arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (cll), a slowly progressing cancer of the blood and bone marrow.arzerra” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2009 at 2:22 pm By:
FDA Approves New Treatment For Chronic Lymphocytic Leukemia: The U.S. Food and Drug Administration approved Arz.. http://bit.ly/kc5wc
ROCHE | Health Canada Approves Rituxan for Treatment of Most Common Adult Leukemia
newswire.ca — “ROCHE | Health Canada Approves Rituxan for Treatment of Most Common Adult Leukemia” View full resource at newswire.ca
Most Recently Shared on August 17, 2009 at 4:52 pm By:
Health Canada approves Rituxin in combo with FC chemo to treat adult lymphocytic #leukemia. http://bit.ly/rCJaB
Advertisement
